Navidea biopharmaceuticals, inc. welcomes dana j moss, jd to board of directors; amit bhalla steps down

Dublin, ohio--(business wire)--navidea biopharmaceuticals, inc. (nyse american: navb) (“navidea” or the “company”), a company focused on the development of precision immunodiagnostic agents and immunotherapeutics, today announced dana j moss, jd has joined the company's board of directors, adding depth in legal advice, strategic business, life sciences and technology in line with navidea's stated objectives and its fix, fund, propel approach to advancing innovative technology to market. separat.
NAVB Ratings Summary
NAVB Quant Ranking